Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease. - Wikidata - wikimedia - TriplyDB

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

http://www.wikidata.org/entity/Q30493249

about

Prion diseases: immunotargets and therapy Theoretical Approaches to Lentiviral Mediated Neurotrophin Delivery in Potential Treatments of Parkinson's Disease Immunotherapy in Parkinson's Disease: Micromanaging Alpha-Synuclein Aggregation Bridge between neuroimmunity and traumatic brain injury How do immune cells support and shape the brain in health, disease, and aging?Utilizing regulatory T cells against rheumatoid arthritis Neuroantibody biomarkers: links and challenges in environmental neurodegeneration and autoimmunity Vaccination strategies for Parkinson disease: induction of a swift attack or raising tolerance?The dopaminergic system in autoimmune diseases Neuroimmunological processes in Parkinson's disease and their relation to α-synuclein: microglia as the referee between neuronal processes and peripheral immunity Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells Friend or foe: the dichotomous impact of T cells on neuro-de/re-generation during aging Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease.Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.Molecular dialogs between the ischemic brain and the peripheral immune system: dualistic roles in injury and repair Systemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study.Functional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage.BCG vaccine-induced neuroprotection in a mouse model of Parkinson's disease.Evidence of inflammatory system involvement in Parkinson's disease.Glia maturation factor deficiency suppresses 1-methyl-4-phenylpyridinium-induced oxidative stress in astrocytes Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases Vasoactive intestinal peptide: a neuropeptide with pleiotropic immune functions.Loss and dysregulation of Th17 cells during HIV infection.T-Lymphocyte Deficiency Exacerbates Behavioral Deficits in the 6-OHDA Unilateral Lesion Rat Model for Parkinson's Disease.The endotoxin-induced neuroinflammation model of Parkinson's disease.Granulocyte-macrophage colony stimulating factor exerts protective and immunomodulatory effects in cortical trauma Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis.Dual destructive and protective roles of adaptive immunity in neurodegenerative disorders.Chaperoned amyloid proteins for immune manipulation: α-Synuclein/Hsp70 shifts immunity toward a modulatory phenotype Role of α-synuclein in inducing innate and adaptive immunity in Parkinson disease.Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue.The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood.Interleukin17A Promotes Postoperative Cognitive Dysfunction by Triggering β-Amyloid Accumulation via the Transforming Growth Factor-β (TGFβ)/Smad Signaling Pathway Evidence for angiogenesis in Parkinson's disease, incidental Lewy body disease, and progressive supranuclear palsy Inhibition of Calpain Activation Protects MPTP-Induced Nigral and Spinal Cord Neurodegeneration, Reduces Inflammation, and Improves Gait Dynamics in Mice.Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy.A model of nitric oxide induced α-synuclein misfolding in Parkinson's disease.Taking the Perspective that a Depressive State Reflects Inflammation: Implications for the Use of Antidepressants A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders Selective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.

P2860

Q26741258-D8424914-C63B-4457-B219-1E0F50696AFF Q26746174-DA73FEF6-8425-4C07-8923-219082E3F4DF Q26781130-A5E20343-72BC-4ADC-BDE7-2B8ED2F5481F Q26827612-CEC9FEB3-9163-43AC-BE26-B36C9AE98584 Q26995364-8677DC2B-3F47-4ED3-854C-B41B0734F71F Q27009990-08F4432F-D042-4FBF-A793-67641BCEBCE8 Q27010245-E41EAA4B-75E5-4915-B0CE-9C01DE00A48B Q27015811-0558B84F-6148-4456-8DC0-1A0E0B39A092 Q27023885-A30C4310-D4F7-4820-AB4E-CCF3B975AA9F Q27027973-87D90212-C50E-445D-9592-8DF1A51326C2 Q27317159-E525CECB-4E37-4FDF-AD92-2C08FD944ED4 Q28077869-DAAE1889-6F40-4E43-9193-90EF4F154E74 Q28943440-96F78884-0150-4F67-852C-653C1E7A719B Q31109638-4D30EAFA-6E85-4430-A794-757BB3F75EC6 Q33583258-CB63E503-875E-4E53-8CE1-559F90C2A0E8 Q33677692-C10F31B4-DC6A-4F9F-ACCF-E453E63AF656 Q33721196-0B8DEBC3-B541-41B6-94C0-B8BE43CBBAED Q33815568-F7A46260-BBDB-4387-94A4-87AD23E7C41A Q33890818-0A05FDF4-0959-470F-A9F4-E9E43D6627F2 Q33911558-2064256F-7F84-4DAD-BBF0-1290BBC02E61 Q34071942-C69B3413-B180-49C5-96C9-00B29E7516FC Q34238010-FFE062A3-07A4-4EC3-BDA4-0AA306B73372 Q34350569-32D40F14-693E-475D-AC2D-26402EB4F92F Q34392867-5DC22AAF-FA20-4DF2-8CE0-AD2D17ED6166 Q34557246-87BAD8CD-C0C8-42B3-BC85-4725E1EAB69A Q34980223-F481A71F-A84E-4346-A56A-50914E32832D Q34992177-00929306-9267-4278-9021-3377D4AA7701 Q35068792-D53068FF-2286-481F-B471-31CB87EDD547 Q35285839-648A38CD-CBCD-453A-AB06-18943C01910C Q35510197-021E2AE1-6D1C-46EF-9DB9-ABB6E5ADB013 Q35586932-17E4F2A9-11CA-49D6-9460-ABB6105A5D0E Q35799403-F06419C8-AD1E-4F9D-889C-910369D10B18 Q35824163-918AE3C6-999C-4A3B-B8A4-C9E7C47AC5DC Q35960407-535F274B-9090-4933-9C4A-199A189182C7 Q36021445-6B1855DD-23E5-420E-AFF8-DCDC4B981E74 Q36085162-8EF73681-4F4B-4B6F-BE21-7B03C407002F Q36129283-F6DA3651-BF44-401F-82CC-1C63241E89C5 Q36171115-78357848-B414-4FBE-9628-A18A524CF859 Q36326816-E1AEA639-3DDB-44FD-9673-DC0072E48260 Q36373813-981FE6DF-DA1D-4127-AC33-632145D2C938

P2860

Regulatory T cells attenuate Th17 cell-mediated nigrostriatal dopaminergic neurodegeneration in a model of Parkinson's disease.

http://www.wikidata.org/entity/Q30493249

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Regulatory T cells attenuate T ...... model of Parkinson's disease.

@ast

Regulatory T cells attenuate T ...... model of Parkinson's disease.

@en

type

label

Regulatory T cells attenuate T ...... model of Parkinson's disease.

@ast

Regulatory T cells attenuate T ...... model of Parkinson's disease.

@en

prefLabel

Regulatory T cells attenuate T ...... model of Parkinson's disease.

@ast

Regulatory T cells attenuate T ...... model of Parkinson's disease.

@en

P1433

Q30493249-FB78DA33-517F-411E-B913-7F873D303C23

P1476

Q30493249-12E38233-EE26-45B2-8BD0-21347F898A72

P2093

Q30493249-0248925E-A1AA-4E5F-A73B-68E6AFC3E615

Q30493249-43FB960C-5FCF-445A-866D-7911CF2ACAB0

Q30493249-6BD019CB-E8F0-4FF2-8173-CB1EB7ED14D7

Q30493249-9FE4E8CE-357A-4E24-87A0-4B490EA700A7

Q30493249-D1738543-F917-403E-A8B2-6715B4BD5C09

Q30493249-E8BDD324-11A2-4193-BEA9-F3904A6F6F98

P2860

Q30493249-0367A3D0-5AE5-4478-B0F6-BD9EED0640F0

Q30493249-0CE6E165-4F5F-4455-BBD1-02FAAAE5D11F

Q30493249-0F333573-5D27-49BE-BA8E-A57181650A52

Q30493249-14911339-03F9-44C3-A68C-6A0351810679

Q30493249-1C382372-ABEE-4571-9A76-3E4034030C04

Q30493249-22DB0EFD-B459-4128-B1E2-01347F6751EE

Q30493249-293275F1-FA55-4072-B992-3F079383BE21

Q30493249-3B8B6DB4-0758-4750-A0DB-C2417A221D61

Q30493249-3D7D6685-1DF3-416F-B249-01E0482170BF

Q30493249-57A163B2-B0FA-48A0-B124-9BE660A41264

P304

Q30493249-E139F063-3951-48CD-A319-82E7320452FA

P31

Q30493249-007C0264-B6D7-48CF-B67F-248137CD6850

P356

Q30493249-74F6F25C-85E8-4212-B77A-BDBDC82917F4

P407

Q30493249-AEC109AE-A7E2-46A9-AB8F-EA9A784863FD

P433

Q30493249-C11272D5-8D8A-41D6-A3C4-6007ADD39F21

P478

Q30493249-FAE04BAF-32C1-43BD-9578-9074D798D3BA

P577

Q30493249-8AF5D25B-26AB-4A18-95BD-7BCD7794F3B9

P5875

Q30493249-FCC21467-D63B-41A9-A8F8-3F2E10E11AE6

P698

Q30493249-6B8F32B8-2818-4760-A4A4-7D830804F8F0

P921

Q30493249-DBEDDA9D-6A40-473D-8AA3-33896B4749A7

Q30493249-EDB39355-3348-48C2-AC27-A134C7DC0F79

P932

Q30493249-7FA6C911-14A7-4037-8A74-0BFA8329A9ED

P356

JIMMUNOL.0901852

P1433

Journal of Immunology

P1476

Regulatory T cells attenuate T ...... model of Parkinson's disease.

@en

P2093

Ashley D Reynolds

http://www.w3.org/2001/XMLSchema#string

David K Stone

http://www.w3.org/2001/XMLSchema#string

Eric J Benner

http://www.w3.org/2001/XMLSchema#string

Howard E Gendelman

http://www.w3.org/2001/XMLSchema#string

Jessica A L Hutter

http://www.w3.org/2001/XMLSchema#string

R Lee Mosley

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha-synuclein in Lewy bodies

Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation

Oxidative post-translational modifications of alpha-synuclein in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.

Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.

Adaptive immune neuroprotection in G93A-SOD1 amyotrophic lateral sclerosis mice.

Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy.

TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology.

CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes/macrophages.

Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease

D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease.

P304

2261-2271

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0901852

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

184

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41191335

http://www.w3.org/2001/XMLSchema#string

P698

20118279

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

P932

2824790

http://www.w3.org/2001/XMLSchema#string